NO934357D0 - Fremgangsm}te for utvinning av proinsulin med korrekt forbundene cystinbruer - Google Patents

Fremgangsm}te for utvinning av proinsulin med korrekt forbundene cystinbruer

Info

Publication number
NO934357D0
NO934357D0 NO934357A NO934357A NO934357D0 NO 934357 D0 NO934357 D0 NO 934357D0 NO 934357 A NO934357 A NO 934357A NO 934357 A NO934357 A NO 934357A NO 934357 D0 NO934357 D0 NO 934357D0
Authority
NO
Norway
Prior art keywords
proinsulin
recovery
cystine bridges
linked cystine
properly linked
Prior art date
Application number
NO934357A
Other languages
English (en)
Other versions
NO934357L (no
NO308216B1 (no
Inventor
Rainer Obermeier
Martin Gerl
Juergen Ludwig
Walter Sabel
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO934357D0 publication Critical patent/NO934357D0/no
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO934357L publication Critical patent/NO934357L/no
Publication of NO308216B1 publication Critical patent/NO308216B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO934357A 1992-12-02 1993-12-01 FremgangsmÕte for utvinning av proinsulin med korrekt forbundede cystinbroer NO308216B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4240420 1992-12-02

Publications (3)

Publication Number Publication Date
NO934357D0 true NO934357D0 (no) 1993-11-30
NO934357L NO934357L (no) 1994-06-03
NO308216B1 NO308216B1 (no) 2000-08-14

Family

ID=6474135

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934357A NO308216B1 (no) 1992-12-02 1993-12-01 FremgangsmÕte for utvinning av proinsulin med korrekt forbundede cystinbroer

Country Status (13)

Country Link
US (1) US5473049A (no)
EP (1) EP0600372B1 (no)
JP (1) JP2798351B2 (no)
AT (1) ATE148710T1 (no)
AU (1) AU662083B2 (no)
CA (1) CA2110442C (no)
DE (1) DE59305396D1 (no)
DK (1) DK0600372T3 (no)
ES (1) ES2097426T3 (no)
FI (1) FI108727B (no)
HK (1) HK1006170A1 (no)
NO (1) NO308216B1 (no)
SG (1) SG46612A1 (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4405179A1 (de) * 1994-02-18 1995-08-24 Hoechst Ag Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
CA2213301C (en) * 1995-02-20 2010-01-26 Amrad Operations Pty. Ltd. Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (iddm)
SE9504019D0 (sv) * 1995-11-13 1995-11-13 Pharmacia Ab Method for production of proteins
DK0821006T3 (da) 1996-07-26 2004-08-16 Aventis Pharma Gmbh Insulinderivater med öget zinkbinding
DE19726167B4 (de) 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
DE19735711C2 (de) * 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
KR100253916B1 (ko) * 1997-12-29 2000-05-01 김충환 사람 인슐린 전구체의 제조방법
DE69840035D1 (de) 1998-03-31 2008-10-30 Tonghua Gantech Biotechnology Chimäres protein welches eine intramolekulare chap zur insulinproduktion
DE19825447A1 (de) 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
DE19838097A1 (de) 1998-08-24 2000-03-02 Hoechst Marion Roussel De Gmbh Verfahren zur chromatographischen Reinigung von Insulinen
PT1141014E (pt) 1999-01-06 2005-04-29 Genentech Inc Variante mutante do factor de crescimento semelhante a insulina (igf-i)
JP2002535967A (ja) * 1999-01-06 2002-10-29 ジェネンテック・インコーポレーテッド インシュリン様成長因子（ｉｇｆ）ｉ変異体
JP3406244B2 (ja) 1999-04-30 2003-05-12 伊藤ハム株式会社 新規な融合蛋白質からの組み換えインスリンの製造方法
WO2001046453A1 (en) 1999-12-22 2001-06-28 Novo Nordisk A/S Method for extractive refolding of scrambled single-chain polypeptides
US20020164712A1 (en) * 2000-12-11 2002-11-07 Tonghua Gantech Biotechnology Ltd. Chimeric protein containing an intramolecular chaperone-like sequence
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
DE10235168A1 (de) * 2002-08-01 2004-02-12 Aventis Pharma Deutschland Gmbh Verfahren zur Reinigung von Preproinsulin
US7193035B2 (en) * 2002-10-29 2007-03-20 Sanofi-Aventis Deutschland Gmbh Crystals of insulin analogs and processes for their preparation
EP2128252A4 (en) * 2008-02-12 2011-03-16 Ils Inc FUSIONED PROTEIN WITH INSULIN PROCESSORS OF THE OVEREXPRESSION AND SECRETION TYPE, DNA THAT COVERS AND METHOD OF INSULIN PRODUCTION
WO2009133529A2 (en) * 2008-04-30 2009-11-05 Wockhardt Research Centre Processes for refolding of insulin
CN102256618A (zh) 2008-10-17 2011-11-23 赛诺菲-安万特德国有限公司 胰岛素和glp-1激动剂的组合
PL2451437T3 (pl) 2009-07-06 2017-05-31 Sanofi-Aventis Deutschland Gmbh Wodne preparaty insuliny zawierające metioninę
TR201809460T4 (tr) 2009-11-13 2018-07-23 Sanofi Aventis Deutschland Bir GLP- 1-agonisti, bir insülin ve metiyonin içeren farmasötik bileşim.
NZ599847A (en) 2009-11-13 2013-09-27 Sanofi Aventis Deutschland Pharmaceutical composition comprising a glp-1 agonist and methionine
WO2012028172A1 (en) 2010-08-30 2012-03-08 Sanofi-Aventis Deutschland Gmbh Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
AR087693A1 (es) 2011-08-29 2014-04-09 Sanofi Aventis Deutschland Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
EP2931301B2 (en) 2012-12-17 2021-09-15 Merck Sharp & Dohme Corp. Process for purifying insulin and analogues thereof
EP3116531B1 (en) 2014-03-14 2021-10-20 Merck Sharp & Dohme Corp. Purifying insulin using cation exchange and reverse phase chromatography in the presence of an organic modifier and elevated temperature
PE20171622A1 (es) 2014-12-12 2017-11-02 Sanofi Aventis Deutschland Formulacion de relacion fija de insulina glargina/lixisenatida
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
US10745457B2 (en) 2015-09-02 2020-08-18 Merck Sharp & Dohme Corp. Process for obtaining insulin with correctly formed disulfide bonds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO81951B (ro) 1980-03-27 1984-02-28 Eli Lilly And Company Procedeu de preparare a unui precursor de insulina
US4430266A (en) * 1980-11-28 1984-02-07 Eli Lilly And Company Process for producing an insulin precursor
NZ199391A (en) 1981-01-02 1985-12-13 Genentech Inc Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
DE3501641A1 (de) * 1985-01-19 1986-07-24 Hoechst Ag, 6230 Frankfurt Verfahren zur gewinnung von insulin-vorlaeufern aus reaktionsgemischen, die bei der faltung von insulin-vorlaeufern aus den entsprechenden s-sulfonaten anfallen
DE3537708A1 (de) 1985-10-23 1987-04-23 Boehringer Mannheim Gmbh Verfahren zur aktivierung von t-pa nach expression in prokaryonten
DE4012818A1 (de) 1990-04-21 1991-10-24 Hoechst Ag Verfahren zur herstellung von fremdproteinen in streptomyceten
DE3726655A1 (de) * 1987-08-11 1989-02-23 Hoechst Ag Verfahren zur isolierung basischer proteine aus proteingemischen, welche solche basischen proteine enthalten
ATE101620T1 (de) 1988-06-23 1994-03-15 Hoechst Ag Mini-proinsulin, seine herstellung und verwendung.
GB8819826D0 (en) * 1988-08-20 1988-09-21 Kabivitrum Ab Glycosylated igf-1
DE3901719A1 (de) * 1989-01-21 1990-07-26 Hoechst Ag Verfahren zur herstellung eines insulinvorlaeufers
IL95495A (en) * 1989-08-29 1996-10-16 Hoechst Ag Fusion proteins their preparation and use
US5227293A (en) * 1989-08-29 1993-07-13 The General Hospital Corporation Fusion proteins, their preparation and use

Also Published As

Publication number Publication date
FI108727B (fi) 2002-03-15
DE59305396D1 (de) 1997-03-20
NO934357L (no) 1994-06-03
AU662083B2 (en) 1995-08-17
NO308216B1 (no) 2000-08-14
SG46612A1 (en) 1998-02-20
FI935358A0 (fi) 1993-11-30
ATE148710T1 (de) 1997-02-15
ES2097426T3 (es) 1997-04-01
JPH06228191A (ja) 1994-08-16
AU5203993A (en) 1994-06-16
EP0600372B1 (de) 1997-02-05
DK0600372T3 (da) 1997-08-11
US5473049A (en) 1995-12-05
CA2110442C (en) 2004-05-04
CA2110442A1 (en) 1994-06-03
HK1006170A1 (en) 1999-02-12
EP0600372A1 (de) 1994-06-08
FI935358L (fi) 1994-06-03
JP2798351B2 (ja) 1998-09-17

Similar Documents

Publication Publication Date Title
NO934357D0 (no) Fremgangsm}te for utvinning av proinsulin med korrekt forbundene cystinbruer
CA2142780A1 (en) Process for obtaining insulin having correctly linked cystine bridges
NO913186D0 (no) Fremgangsmaate for anvendelse og syntese av peptider.
GB8916806D0 (en) Modified proteins
DK0463450T3 (da) Vasoaktive intestinale polypeptid-analoger og udnyttelsen heraf
GB8826451D0 (en) Improvements in/relating to organic compounds
ATE265498T1 (de) Azoverbindungen und verfahren zur herstellung derselben
DK0585939T4 (da) TNF-ligander
EP0282317A3 (en) Purified platelet-derived growth factor and methods for purification thereof
DE59409672D1 (de) Festphasensynthese von Oligoribonucleotiden
DK96390A (da) Copoly-(arylensulfider) og fremgangsmaade til deres fremstilling
IL98225A0 (en) Separation of organic compounds from a mixture
BR8600260A (pt) Processo para a preparacao de triacetoxissilanas a partir de tris(amino)silanas
BR9001703A (pt) Processo para separar glicina e sulfato de sodio decaidratado;processo para precipitar glicina e sulfato de sodio decaidratado;processo para a separacao continua de glicina e sulfato de sodio decaidratado;e processo para recuperar glicina
WO1994021812A3 (en) Hepatitis b escape mutant specific binding molecules
DK0612745T3 (da) Fremgangsmåde til fremstilling af 1,2,3,4,10,14b-hexahydro-2-methyl-dibenzo[c,f]pyrazino[1,2-a]azepin og salte deraf
FI921356A0 (fi) Somatostatinreceptor.
DE3476390D1 (en) Chemical process
KR960008941B1 (en) Dual combustion zone sulfur recovery process
DE3573111D1 (en) Process for separating methyl isocyanate
Մուրադյան The Armenian Inscriptions from the Sinai. Edited by Michael E. Stone. With Appendixes by Michel van Esbroeck and Wiliam Adler. Harvard University Press Cambridge, Massachusetts, IX+ 197 p.+ CXXIII Pl.
IT1230519B (it) Miscela di caucciu' reticolabile, in particolare vulcanizzabile mediante zolfo.